Use of α2δ Ligands for Restless Legs Syndrome/Willis Ekbom Disease
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical)
Link
http://link.springer.com/article/10.1007/s40263-018-0502-z/fulltext.html
Reference102 articles.
1. Silber MH, Becker PM, Earley C, et al. Willis–Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome. Mayo Clin Proc. 2013;88:977–86.
2. Hening W, Walters AS, Allen RP, et al. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med. 2004;5(3):237–46.
3. Winkelmann J, Schadrack J, Wetter TC, et al. Opioid and dopamine antagonist drug challenges in untreated restless legs syndrome patients. Sleep Med. 2001;2:57–61.
4. Picchietti DL, Picchietti MA. Restless legs syndrome: what have we learned from prevalence studies and how will incidence studies further clinical knowledge? J Clin Sleep Med. 2012;8:119–24.
5. Allen RP, Earley CJ. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol. 2001;18:128–47.
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Síndrome de piernas inquietas. Fisiopatología, diagnóstico y tratamiento;Medicina Clínica;2024-08
2. A comprehensive update on the ADMET considerations for α2δ calcium channel ligand medications for treating restless legs syndrome;Expert Opinion on Drug Metabolism & Toxicology;2024-03-03
3. Towards Multitargeted Ligands as Pain Therapeutics: Dual Ligands of the Cavα2δ‐1 Subunit of Voltage‐Gated Calcium Channel and the μ‐Opioid Receptor;ChemMedChem;2024-01-17
4. Circadian rhythm in restless legs syndrome;Frontiers in Neurology;2023-02-23
5. Available Treatment Modules for Brain Disorders;Food Bioactive Ingredients;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3